Xtant Medical Holdings, Inc. Reports Net Loss of $4.3 Million for the Second Quarter of 2023
Revenue Surges to $20.2 Million for Xtant Medical Holdings, Inc. in the Second Quarter of 2023
Xtant Medical Holdings, Inc.(XTMTW), a leading medical device company, h as released its unaudited financial results for the second quarter ended June 30, 2023. The company reported a net loss of $4.3 million for the quarter, reflecting ongoing challenges in the healthcare industry. However, there was a significant increase in revenue, reaching $20.2 million for the same period. Let's delve into the details of the company's financial performance.
Net Income/Loss
In the second quarter of 2023, Xtant Medical Holdings, Inc. faced a net loss of $4.3 million. This figure reflects the expenses incurred and challenges faced by the company during the three-month period. Despite the loss, the company remains committed to its strategic initiatives and looks to rebound in subsequent quarters.
Revenue